Leerink Partnrs Issues Negative Forecast for DNLI Earnings
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of Denali Therapeutics in a report released on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($0.68) per share for the quarter, down from their previous estimate of […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Leerink Partnrs dropped their Q3 2025 earnings estimates for shares of Denali Therapeutics in a report released on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now anticipates that the company will post earnings of ($0.68) per share for the quarter, down from their previous estimate of […]
